SHI
ISEE

SV Health Investors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

SV Health Investors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,103,981
Closed -$44.7M – 7
2015
Q3 		$44.7M Sell
1,103,981
-293,275
-21% -$15.5M 25.02% 2
2015
Q2 		$72.7M Sell
1,397,256
-655,887
-32% -$32.6M 27.85% 2
2015
Q1 		$95.5M Sell
2,053,143
-568,432
-22% -$29.5M 31.57% 2
2014
Q4 		$118M Sell
2,621,575
-687,120
-21% -$28.9M 58.7% 1
2014
Q3 		$129M Hold
3,308,695
– – 64.27% 1
2014
Q2 		$140M Buy
+3,308,695
New +$121M 78.64% 1

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SV Health Investors's ISEE Position: Q4 2015 in Review

SV Health Investors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2015, closing a stake of 1,103,981 shares — an estimated $44.7M sold.

SV Health Investors first reported a position in ISEE in Q2 2014 and held it in 6 quarters. The position peaked at $140M in Q2 2014. 152 funds tracked by Wall St. Rank hold ISEE as of Q4 2015.

  • SV Health Investors reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • SV Health Investors sold 1,103,981 IVERIC bio, Inc. Common Stock shares in Q4 2015, an estimated $44.7M.
  • SV Health Investors first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 6 quarters.
  • SV Health Investors's IVERIC bio, Inc. Common Stock position peaked at $140M in Q2 2014.
  • 152 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2015.

Based on SV Health Investors's 13F filing for Q4 2015, filed 16 Feb 2016.